DYSPORT® gives you the POWER to deliver LASTING CONTROL with high levels of active neurotoxin (within licensed maximum dose), to help patients achieve MEANINGFUL GOALS.
Experience lasting symptom control
~7 in 10 patients would like longer-lasting benefits
Reliability
Largest reimbursement criteria
Dysport® has the widest indications and reimbursement coverage in spasticity.
Spasticity
Achieve meaningful goals
Dysport® Attain mutually agreed patient goals, cycle after cycle by improving mobility, comfort, and quality of life in upper AND lower limb
Deliver lasting control
Lasting symptom control with Dysport® helps prevent the early return of debilitating symptoms
Power
Unlock the BoNT-A potential
Dysport® contains more active neurotoxin within the licensed maximum dose than any other available BoNT-A10 which give you the flexibility to treat a range of small and large muscles10,11
Switch to Dysport can increase waning time
Data from a pilot single-centre prospective study of 33 chronicaly injected CD patients with waning time less than 8 weeks showed an increase of waning time after converstion to Dysport®
Cervical Dystonia
USP
Proven
Lean on 30 years of experience
A well-characterised safety and efficacy profile is underpinned by over 15 million patient-years of exposure
Call to action
Smooth their path towards progress with Dysport®
Help patients find the lasting relief they desire, from one cycle to the next